Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer
Clinical trial NCT05253066 · UNKNOWN
Trial details
- NCT number
- NCT05253066
- Sponsor
- Shengjing Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-25
- Primary completion
- 2022-07-31
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.